<DOC>
	<DOCNO>NCT01592890</DOCNO>
	<brief_summary>This single-center , open-label study assess excretion balance , pharmacokinetics metabolism oral [ 14C ] -labeled RO4917523 healthy male volunteer . Subjects receive single oral dose [ 14C ] -labeled RO4917523 intravenous tracer dose [ 13C ] -labeled RO4917523 Day 1 . In-clinic period 18 Days . Anticipated time study 15 week .</brief_summary>
	<brief_title>A Study The Excretion Balance , Pharmacokinetics Metabolism A Single Oral Dose 14C-Labeled RO4917523 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Male adult , 18 65 year age inclusive Body mass index ( BMI ) 18.0 32.0 kg/m2 Healthy , judge physician basis medical history , general physical examination , laboratory test , vital sign 12lead ECG Medical history without major pathology Agree use two effective method contraception partner , include one barrier method ( e.g . condom ) throughout study 3 month last dose study drug History relevant drug food allergy Smoking ( within 60 day prior drug administration followup visit ) History alcohol abuse drug addiction ( include soft drug like cannabis product ) Participation drug study within 60 day precede first administration study drug ; participation 3 drug study within 10 month precede first administration study drug Infrequent bowel movement ( less per 2 day ) Participation another ADME study radiation burden &gt; 0,1 mSv period 1 year start study Positive screen drug abuse Average intake 24 unit alcohol per week Positive hepatitis B , hepatitis C HIV infection</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>